Trials / Completed
CompletedNCT00319215
Effects of Ramelteon on Driving Ability
A Study to Investigate the Residual Effects of Ramelteon (8 mg), Zopiclone (7.5 mg) and Placebo on Actual Driving, Memory, Psychomotor Performance and Mood
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (planned)
- Sponsor
- Utrecht Institute for Pharmaceutical Sciences · Academic / Other
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to investigate the effects of bedtime administration of a single dose of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on next-morning on-road driving performance. In addition, the drugs' effects on balance are evaluated during the night, and the next morning residual effects on memory and psychomotor performance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ramelteon 8 mg | |
| DRUG | Zopiclone 7.5 mg |
Timeline
- Start date
- 2006-03-01
- Completion
- 2006-07-01
- First posted
- 2006-04-27
- Last updated
- 2007-04-25
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00319215. Inclusion in this directory is not an endorsement.